233 related articles for article (PubMed ID: 36192632)
1. Alternative RNA splicing modulates ribosomal composition and determines the spatial phenotype of glioblastoma cells.
Larionova TD; Bastola S; Aksinina TE; Anufrieva KS; Wang J; Shender VO; Andreev DE; Kovalenko TF; Arapidi GP; Shnaider PV; Kazakova AN; Latyshev YA; Tatarskiy VV; Shtil AA; Moreau P; Giraud F; Li C; Wang Y; Rubtsova MP; Dontsova OA; Condro M; Ellingson BM; Shakhparonov MI; Kornblum HI; Nakano I; Pavlyukov MS
Nat Cell Biol; 2022 Oct; 24(10):1541-1557. PubMed ID: 36192632
[TBL] [Abstract][Full Text] [Related]
2. SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes.
Song X; Wan X; Huang T; Zeng C; Sastry N; Wu B; James CD; Horbinski C; Nakano I; Zhang W; Hu B; Cheng SY
Cancer Res; 2019 Oct; 79(20):5288-5301. PubMed ID: 31462429
[TBL] [Abstract][Full Text] [Related]
3. The short isoform of MS4A7 is a novel player in glioblastoma microenvironment, M2 macrophage polarization, and tumor progression.
Ni B; Huang G; Yang R; Wang Z; Song H; Li K; Zhang Y; Wu K; Shi G; Wang X; Shen J; Liu Y
J Neuroinflammation; 2023 Mar; 20(1):80. PubMed ID: 36944954
[TBL] [Abstract][Full Text] [Related]
4. Functional genomics analyses of RNA-binding proteins reveal the splicing regulator SNRPB as an oncogenic candidate in glioblastoma.
Correa BR; de Araujo PR; Qiao M; Burns SC; Chen C; Schlegel R; Agarwal S; Galante PA; Penalva LO
Genome Biol; 2016 Jun; 17(1):125. PubMed ID: 27287018
[TBL] [Abstract][Full Text] [Related]
5. The Prognostic Significance of Spliceosomal Proteins for Patients with Glioblastoma.
Larionova TD; Kovalenko TF; Shakhparonov MI; Pavlyukov MS
Dokl Biochem Biophys; 2022 Apr; 503(1):71-75. PubMed ID: 35538281
[TBL] [Abstract][Full Text] [Related]
6. SON drives oncogenic RNA splicing in glioblastoma by regulating PTBP1/PTBP2 switching and RBFOX2 activity.
Kim JH; Jeong K; Li J; Murphy JM; Vukadin L; Stone JK; Richard A; Tran J; Gillespie GY; Flemington EK; Sobol RW; Lim SS; Ahn EE
Nat Commun; 2021 Sep; 12(1):5551. PubMed ID: 34548489
[TBL] [Abstract][Full Text] [Related]
7. CircSMARCA5 Inhibits Migration of Glioblastoma Multiforme Cells by Regulating a Molecular Axis Involving Splicing Factors SRSF1/SRSF3/PTB.
Barbagallo D; Caponnetto A; Cirnigliaro M; Brex D; Barbagallo C; D'Angeli F; Morrone A; Caltabiano R; Barbagallo GM; Ragusa M; Di Pietro C; Hansen TB; Purrello M
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29415469
[TBL] [Abstract][Full Text] [Related]
8. Expression of alternatively spliced mdm2 transcripts correlates with stabilized wild-type p53 protein in human glioblastoma cells.
Kraus A; Neff F; Behn M; Schuermann M; Muenkel K; Schlegel J
Int J Cancer; 1999 Mar; 80(6):930-4. PubMed ID: 10074928
[TBL] [Abstract][Full Text] [Related]
9. N
Li F; Yi Y; Miao Y; Long W; Long T; Chen S; Cheng W; Zou C; Zheng Y; Wu X; Ding J; Zhu K; Chen D; Xu Q; Wang J; Liu Q; Zhi F; Ren J; Cao Q; Zhao W
Cancer Res; 2019 Nov; 79(22):5785-5798. PubMed ID: 31530567
[TBL] [Abstract][Full Text] [Related]
10. The aberrant splicing of BAF45d links splicing regulation and transcription in glioblastoma.
Aldave G; Gonzalez-Huarriz M; Rubio A; Romero JP; Ravi D; Miñana B; Cuadrado-Tejedor M; García-Osta A; Verhaak R; Xipell E; Martinez-Vélez N; de la Rocha AA; Puigdelloses M; García-Moure M; Marigil M; Gállego Pérez-Larraya J; Marín-Bejar O; Huarte M; Carro MS; Ferrarese R; Belda-Iniesta C; Ayuso A; Prat-Acín R; Pastor F; Díez-Valle R; Tejada S; Alonso MM
Neuro Oncol; 2018 Jun; 20(7):930-941. PubMed ID: 29373718
[TBL] [Abstract][Full Text] [Related]
11. Selective expression of CD44 messenger RNA splice variants in four high grade human brain tumour cell lines.
Harn HJ; Lee HS; Ho LI; Lee WH; Ding JH
Biochem Mol Biol Int; 1994 Jul; 33(4):743-9. PubMed ID: 7526922
[TBL] [Abstract][Full Text] [Related]
12. Studying Isoform-Specific mRNA Recruitment to Polyribosomes with Frac-seq.
Martinez-Nunez RT; Sanford JR
Methods Mol Biol; 2016; 1358():99-108. PubMed ID: 26463379
[TBL] [Abstract][Full Text] [Related]
13. Extracellular Vesicles Released by Glioblastoma Cells Stimulate Normal Astrocytes to Acquire a Tumor-Supportive Phenotype Via p53 and MYC Signaling Pathways.
Hallal S; Mallawaaratchy DM; Wei H; Ebrahimkhani S; Stringer BW; Day BW; Boyd AW; Guillemin GJ; Buckland ME; Kaufman KL
Mol Neurobiol; 2019 Jun; 56(6):4566-4581. PubMed ID: 30353492
[TBL] [Abstract][Full Text] [Related]
14. FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma.
Srivastava C; Irshad K; Dikshit B; Chattopadhyay P; Sarkar C; Gupta DK; Sinha S; Chosdol K
Int J Cancer; 2018 Feb; 142(4):805-812. PubMed ID: 28994107
[TBL] [Abstract][Full Text] [Related]
15. Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas.
Lefave CV; Squatrito M; Vorlova S; Rocco GL; Brennan CW; Holland EC; Pan YX; Cartegni L
EMBO J; 2011 Sep; 30(19):4084-97. PubMed ID: 21915099
[TBL] [Abstract][Full Text] [Related]
16. Splicing is an alternate oncogenic pathway activation mechanism in glioma.
Siddaway R; Milos S; Vadivel AKA; Dobson THW; Swaminathan J; Ryall S; Pajovic S; Patel PG; Nazarian J; Becher O; Brudno M; Ramani A; Gopalakrishnan V; Hawkins C
Nat Commun; 2022 Jan; 13(1):588. PubMed ID: 35102191
[TBL] [Abstract][Full Text] [Related]
17. Targeting the splicing factor NONO inhibits GBM progression through GPX1 intron retention.
Wang X; Han M; Wang S; Sun Y; Zhao W; Xue Z; Liang X; Huang B; Li G; Chen A; Li X; Wang J
Theranostics; 2022; 12(12):5451-5469. PubMed ID: 35910786
[No Abstract] [Full Text] [Related]
18. Binding of SRSF4 to a novel enhancer modulates splicing of exon 6 of Fas pre-mRNA.
Jang HN; Liu Y; Choi N; Oh J; Ha J; Zheng X; Shen H
Biochem Biophys Res Commun; 2018 Nov; 506(3):703-708. PubMed ID: 30376989
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of GFAPkappa, a novel glial fibrillary acidic protein isoform.
Blechingberg J; Holm IE; Nielsen KB; Jensen TH; Jørgensen AL; Nielsen AL
Glia; 2007 Apr; 55(5):497-507. PubMed ID: 17203480
[TBL] [Abstract][Full Text] [Related]
20. Spliceosome-regulated RSRP1-dependent NF-κB activation promotes the glioblastoma mesenchymal phenotype.
Li Y; Wang X; Qi S; Gao L; Huang G; Ren Z; Li K; Peng Y; Yi G; Guo J; Yang R; Wang H; Zhang X; Liu Y
Neuro Oncol; 2021 Oct; 23(10):1693-1708. PubMed ID: 34042961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
